Smoking rates declined globally for the first time on record, according to a new report on tobacco use. However, the figures from the Tobacco Atlas report also mask growing numbers of smokers in parts of the world, as well as increased tobacco use among young teenagers in almost half of the countries surveyed.

The U.S. Food and Drug Administration on April 28 issued a long-awaited proposal to ban menthol cigarettes and flavored cigars, a major victory for anti-smoking advocates but one that could face stiff opposition from Big Tobacco.

Medicago’s COVID-19 vaccine – approved during February in Canada – is facing limited growth in the near term after the World Health Organization said it would not review the vaccine because the company is partly owned by U.S.-Swiss tobacco company Philip Morris, health experts say.

A federal judge on February 16 dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc. of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug.

Pfizer Inc. said on Sept. 16 the company was recalling all lots of the anti-smoking treatment Chantix due to high levels of cancer-causing agents called nitrosamines in the pills.

The U.S. Food and Drug Administration said on Sept. 9 the regulatory agency needs more time to decide whether e-cigarette maker Juul Labs Inc. and other major manufacturers can sell their products in the United States.

More than 55 million people worldwide are living with dementia, a neurological disorder that robs them of their memory and costs the world $1.3 trillion a year, the World Health Organization (WHO) said on Sept. 2.

Pfizer Inc. said on Aug. 13 the company is recalling four additional lots of the anti-smoking treatment Chantix after finding elevated levels of cancer-causing agents called nitrosamines in the pills.

Pfizer issued a voluntary recall for 12 lots of the company’s anti-smoking drug Chantix (varenicline) due to the presence of a nitrosamine impurity exceeding the company’s established Acceptable Daily Intake (ADI) level. As a result, Pfizer is pausing distribution of Chantix and is accelerating the company’s internal testing of the product.

The U.S. drug regulator said on July 16 the FDA will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc. halted distribution of the company’s Chantix branded varenicline.